Esaar (India)

Why is Esaar (India) Ltd falling/rising?

As of 19-Jun, Esaar (India) Ltd's stock price is at 12.50, down 0.56% after three days of gains, indicating a trend reversal. Despite this short-term decline, the stock has strong long-term performance and increased investor interest, suggesting a generally positive outlook.

As of 19-Jun, Esaar (India) Ltd's stock price is currently at 12.50, reflecting a decrease of 0.07 or 0.56%. This decline comes after a period of three consecutive days of gains, indicating a trend reversal. Despite this recent drop, the stock has shown strong performance over various time frames, including a 1-week increase of 2.71% and a 1-month increase of 12.61%, significantly outperforming the Sensex during these periods.<BR><BR>Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically suggests a bullish trend. Furthermore, there has been a notable increase in investor participation, with delivery volume rising by 188.41% compared to the 5-day average, indicating heightened interest in the stock.<BR><BR>However, it is important to note that today's performance has underperformed the sector by 0.85%, which may contribute to the current price decline. Overall, while the stock is experiencing a short-term fall, its longer-term performance and increased investor activity suggest a generally positive outlook.

Which are the latest news on Esaar (India)?

Should I buy, sell or hold Esaar (India) Ltd?

How big is Esaar (India)?

As of 10th June, Esaar (India) Ltd has a market capitalization of 24.00 Cr, with recent net sales of 40.71 Cr and a net profit of 11.13 Cr. The company reported shareholder's funds of 23.40 Cr and total assets of 108.38 Cr for the annual period ending in March 2025.

As of 10th June, Esaar (India) Ltd has a market capitalization of 24.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Esaar (India) reported Net Sales of 40.71 Cr and a Net Profit of 11.13 Cr.<BR><BR>For the latest annual period ending in March 2025, the company had Shareholder's Funds of 23.40 Cr and Total Assets amounting to 108.38 Cr.

Who are in the management team of Esaar (India)?

The management team of Esaar (India) includes Dipti Yelve (Non-Executive & Independent Director), Mehul Shah, Vaibhav Shastri, and Raju Darade (all Independent Directors), Shruti Rahul Joshi (Chairperson, Whole-Time Director, and CFO), and Palak Jain (Company Secretary & Compliance Officer).

The management team of Esaar (India) includes the following individuals:<BR><BR>1. **Dipti Yelve** - Non-Executive & Independent Director<BR>2. **Mehul Shah** - Independent Director<BR>3. **Vaibhav Shastri** - Independent Director<BR>4. **Raju Darade** - Independent Director<BR>5. **Shruti Rahul Joshi** - Chairperson, Whole-Time Director, and CFO<BR>6. **Palak Jain** - Company Secretary & Compliance Officer<BR><BR>If you have any more questions about the company or its management, feel free to ask!

Who are the peers of the Esaar (India)?

Esaar (India) peers include Innovative Ideal, Johnson Pharma, Monotype India, Kaarya Facilit., ERP Soft Systems, Zenlabs Ethica, Gemstone Invest., and Sawaca Enterprises. Esaar has average management risk and good growth, with a 1-year return of 10.91%, while Kaarya Facilit. leads with a 289.97% return and Johnson Pharma lags at -43.33%.

Peers: The peers of Esaar (India) are Innovative Ideal, Johnson Pharma, Monotype India, Kaarya Facilit., ERP Soft Systems, Zenlabs Ethica, Gemstone Invest., and Sawaca Enterpri.<BR><BR>Quality Snapshot: Below Average management risk is observed at Innovative Ideal, Kaarya Facilit., ERP Soft Systems, Zenlabs Ethica, Gemstone Invest., and Sawaca Enterpri. Average management risk is found at Esaar (India). Johnson Pharma has a Good capital structure, while Excellent capital structure is noted at ERP Soft Systems and Gemstone Invest. Esaar (India) shows Good growth, while Average growth is seen at Johnson Pharma, and Below Average growth is present at Innovative Ideal, Kaarya Facilit., ERP Soft Systems, Zenlabs Ethica, and Sawaca Enterpri.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kaarya Facilit. at 289.97%, while Johnson Pharma has the lowest at -43.33%. Esaar (India) has a 1-year return of 10.91%, which is significantly higher than Johnson Pharma's. Additionally, ERP Soft Systems, Johnson Pharma, Monotype India, Gemstone Invest., and Sawaca Enterpri. all show negative six-month returns.

What does Esaar (India) do?

Esaar (India) Ltd is a Non-Banking Financial Company (NBFC) providing asset finance, with a market cap of INR 24 Cr. As of March 2026, it reported net sales of 21 Cr and a net profit of 25 Cr.

Overview: <BR>Esaar (India) Ltd is a Non-Banking Financial Company (NBFC) engaged in providing asset finance, operating within the diversified commercial services industry and categorized as a micro-cap company.<BR><BR>History: <BR>Esaar (India) Ltd was originally incorporated on August 23, 1951, as M/s. Essar (India) Private Limited. The company changed its name to Esaar (India) Limited on May 8, 1995. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 21 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 25 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 24 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 2.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.19 <BR>Return on Equity: 28.14% <BR>Price to Book: 0.62 <BR><BR>Contact Details: <BR>Address: 204 B-Wing Chikuwadi Plot-115, W E Highway Andheri East Mumbai Maharashtra : 400099 <BR>Email: esaarindialtd@gmail.com <BR>Website: http://www.esaarindia.wordpress.com

Are Esaar (India) Ltd latest results good or bad?

Esaar (India) Ltd's latest Q4 FY26 results show impressive growth in net profit and sales, but the reliance on non-operating income and negative return on equity raise concerns about sustainability and financial health. Investors should be cautious due to underlying weaknesses despite the strong figures.

Esaar (India) Ltd's latest results for Q4 FY26 present a mixed picture, characterized by significant volatility and concerning underlying issues. On one hand, the company reported a net profit of ₹25.01 crores, a remarkable increase of 390.81% quarter-on-quarter, and net sales surged by 674.73% to ₹21.46 crores. These figures suggest a strong rebound from the previous quarter's losses.<BR><BR>However, the quality of this profit is questionable. A substantial portion of the profit—61.88%—came from non-operating income, which raises red flags about the sustainability of these earnings. For a non-banking financial company (NBFC), reliance on non-core income rather than consistent operational performance is a significant concern.<BR><BR>Additionally, the company's return on equity (ROE) is alarmingly negative at -72.09%, indicating that it is currently destroying shareholder value. This contrasts sharply with its historical average ROE of 36.16%, suggesting a severe deterioration in its financial health.<BR><BR>Moreover, the company's balance sheet shows signs of distress, with a current ratio of 0.21, indicating liquidity issues, and a high debt-to-equity ratio of 4.20, which reflects aggressive borrowing.<BR><BR>In summary, while the latest quarterly results show impressive growth figures, the underlying volatility, reliance on non-operating income, and deteriorating financial metrics suggest that the overall outlook for Esaar (India) Ltd is concerning. Investors should approach with caution, as the fundamental weaknesses may outweigh the tactical positives presented in the latest results.

When is the next results date for Esaar (India) Ltd?

The next results date for Esaar (India) Ltd is 29 May 2026.

The next results date for Esaar (India) Ltd is scheduled for 29 May 2026.

Is Esaar (India) overvalued or undervalued?

As of November 17, 2025, Esaar (India) is considered very expensive and overvalued with a PE ratio of -3.12 and high EV multiples, despite a strong year-to-date return of 106%, indicating a significant deterioration in its valuation outlook compared to peers like Bajaj Finance and Life Insurance.

As of 17 November 2025, the valuation grade for Esaar (India) has moved from risky to very expensive, indicating a significant deterioration in its valuation outlook. The company is currently deemed overvalued. Key ratios highlight this concern: the PE ratio stands at -3.12, the EV to EBIT is exceptionally high at 61.45, and the EV to EBITDA is also elevated at 53.20. <BR><BR>In comparison to its peers, Esaar's valuation is starkly out of line; for instance, Bajaj Finance has a PE ratio of 34.85 and an EV to EBITDA of 19.61, while Life Insurance boasts a much more attractive PE of 11.33 and an EV to EBITDA of 9.36. Despite a strong year-to-date return of 106.00% compared to the Sensex's 8.72%, the underlying financial metrics suggest that Esaar is not justified at its current price of 12.36, especially given its negative ROCE of -17.24% and ROE of -34.57%.

How has been the historical performance of Esaar (India)?

Esaar (India) has experienced significant financial fluctuations, with net sales peaking at 21.94 Cr in Mar'21 and declining to 14.77 Cr by Mar'25, alongside a shift from profit to losses in operating profit and net income. Despite a decrease in total liabilities and improved cash flow from operations, the company has faced substantial challenges in recent years.

Answer:<BR>The historical performance of Esaar (India) shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Esaar (India) has experienced varying net sales, peaking at 21.94 Cr in Mar'21 before declining to 14.77 Cr in Mar'25. The total operating income followed a similar trend, reaching a high of 21.94 Cr in Mar'21 and dropping to 14.77 Cr in Mar'25. The company faced challenges with operating profit, showing a negative operating profit of -5.48 Cr in Mar'25, compared to a positive 5.84 Cr in Mar'23. Profit before tax also turned negative in Mar'25 at -1.56 Cr, while profit after tax was -2.24 Cr, reflecting a downward trend from a profit of 4.48 Cr in Mar'23. The company's total liabilities decreased from 157.71 Cr in Mar'23 to 106.09 Cr in Mar'24, with total debt also declining from 106.74 Cr to 41.98 Cr in the same period. Cash flow from operating activities improved to 71 Cr in Mar'24, contrasting with a negative cash flow of -41 Cr in Mar'23. Overall, Esaar (India) has shown volatility in its financial performance, with significant losses in recent years despite some recovery in cash flow.

What is the technical trend for Esaar (India)?

As of May 26, 2025, Esaar (India) shows a mildly bullish trend overall, supported by strong daily moving averages and bullish Bollinger Bands, despite mixed signals from weekly indicators.

As of 26 May 2025, the technical trend for Esaar (India) has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD remains bullish, suggesting mixed signals across time frames. The weekly RSI is bearish, but the monthly RSI shows no signal, indicating a lack of momentum in the longer term. Bollinger Bands are bullish on both weekly and monthly charts, supporting the mildly bullish outlook. Daily moving averages are bullish, reinforcing positive short-term sentiment. The KST shows a mildly bearish trend weekly but is bullish monthly, and Dow Theory reflects a mildly bearish stance weekly while being mildly bullish monthly. Overall, the current technical stance is mildly bullish, driven by strong daily moving averages and consistent bullish signals from Bollinger Bands, despite some bearish indicators on the weekly charts.

Who are the top shareholders of the Esaar (India)?

The top shareholders of Esaar (India) include promoter Dheeraj Shah with 3.1% and public shareholder Mahevarsh Fincon Private Limited with 3.91%. Individual investors hold a significant 72.3%, with no mutual funds or foreign institutional investors involved, and no pledged promoter holdings.

The top shareholders of Esaar (India) include Dheeraj Shah, who is the promoter with the highest holding at 3.1%. The highest public shareholder is Mahevarsh Fincon Private Limited, holding 3.91%. Additionally, individual investors collectively hold a significant portion of the company at 72.3%. There are no mutual funds or foreign institutional investors currently holding shares in the company, and there are no pledged promoter holdings.

What is the bonus history of the Esaar (India)?

Esaar (India) announced a 3:2 bonus issue on October 21, 2014, with a record date of October 22, 2014, allowing shareholders to receive three shares for every two shares held.

Esaar (India) has a bonus history that includes a 3:2 bonus issue announced on October 21, 2014. The record date for this bonus was October 22, 2014. This means that shareholders received three shares for every two shares they held at that time. If you have any more questions about the company or its financial activities, feel free to ask!

Has Esaar (India) declared dividend?

No Dividend History Available